Overview
Herpes zoster pneumonia is a rare complication of herpes zoster (shingles) infection, caused by the reactivation of the varicella-zoster virus (VZV) 1. It occurs when the virus spreads to the lungs, typically in immunocompromised individuals 1.Diagnosis
Diagnosis is typically made based on clinical presentation and confirmed by viral detection in respiratory samples 1.Management
Treatment is primarily supportive, focusing on symptom management and preventing secondary infections 1.
Antiviral medications may be considered in severe cases or in immunocompromised patients 1.Special Populations
Elderly individuals are at higher risk for herpes zoster and its complications 1.
The impact of the recombinant subunit herpes zoster vaccine on cardiovascular events has not been studied 1.Key Recommendations
Consider vaccination against herpes zoster in eligible populations to prevent primary infection and its potential complications 1. (Evidence: Moderate)
Antiviral therapy may be indicated for herpes zoster pneumonia, particularly in immunocompromised individuals 1. (Evidence: Weak)References
1 Addario A, Célarier T, Bongue B, Barth N, Gavazzi G, Botelho-Nevers E. Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review. GeroScience 2023. link